DP-b99

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDP-b99
Drug Alias NameDP-b99DP-Bapta-99
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsIschemic StrokeStrokeBrain Ischemia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm Ltd
Active IndicationsN/A
Inactive IndicationsIschemic StrokeStrokeBrain Ischemia +[5] 

Other Information

ATC CodeN/A
Related LinksDrugBank